NEXT SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.31 AUD | -8.82% |
|
-27.06% | -8.82% |
| 04-24 | Next Science Product Sales Rise 19% to $5.5 Million for March Quarter | MT |
| 04-24 | Transcript : Next Science Limited, Q1 2024 Earnings Call, Apr 24, 2024 |
Chart calendar Next Science Limited
65c4a87d4895548.TiwfrYMAS42zG3UXSKYdBx_wzE4uSxfzvKreuwAoVsU.CVhG3ug0BOT3eSBeJvJWMUaotD9ec0iD9Oaw3XVjZLEnZlH--2Ifvd5ZMA~cef0abe198f9867fd23bfdbb303c878d
Upcoming events on Next Science Limited
Past events on Next Science Limited
| 23/04/2024 23:15 | Q1 2024 Earnings Call |
| 23/04/2024 | March 2024 Earnings Release |
| 27/02/2024 22:30 | Q4 2023 Earnings Call |
| 27/02/2024 21:19 | Q4 2023 Earnings Release |
| 29/01/2024 21:20 | December 2023 Sales and Revenue Release - Activities Report |
| 14/11/2023 | Bell Potter Healthcare Conference |
| 25/10/2023 | Great Wilsons Drug & Device Conference |
| 24/10/2023 23:00 | Shareholders Meeting |
| 23/10/2023 01:31 | September 2023 Sales and Revenue Release - Activities Report |
| 22/10/2023 | September 2023 Sales and Revenue Call - Activities Report |
| 31/08/2023 02:00 | Q2 2023 Earnings Call |
| 31/08/2023 00:52 | Q2 2023 Earnings Release |
| 07/08/2023 | Investor Meeting |
| 26/07/2023 23:22 | June 2023 Sales and Revenue Release - Activity Report |
| 26/07/2023 | June 2023 Sales and Revenue Call - Activities Report |
| 25/05/2023 | Annual General Meeting |
| 21/04/2023 00:36 | March 2023 Sales and Revenue Release - Activities Report |
| 20/04/2023 | March 2023 Sales and Revenue Call - Activities Report |
| 28/02/2023 01:30 | Q4 2022 Earnings Call |
| 27/02/2023 21:48 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,06 4,77 -14.91% | 3,44 3,38 1.66% | 8,95 9,82 -8.91% | 11,7 11,3 3.65% | 22,2 21,6 2.89% | 32,7 |
|
EBITDA Million USD | Released Forecast Spread | -11,9 -11,7 -1.66% | -11,5 -12,9 10.93% | -8,69 -7,61 -14.09% | -11,8 -9,96 -18.56% | -14,8 -16,7 11.28% | -12,0 |
|
EBIT Million USD | Released Forecast Spread | -12,5 -12,4 -0.65% | -12,2 -13,8 11.82% | -9,48 -8,66 -9.42% | -12,7 -11,0 -15.21% | -16,0 -17,2 7.11% | -12,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,4 -14,1 -1.79% | -11,9 -13,4 10.77% | -9,35 -8,75 -6.85% | -12,7 -12,5 -1.47% | -16,3 -17,2 5.4% | -14,8 |
|
Net income Million USD | Released Forecast Spread | -14,4 -12,5 -14.48% | -11,9 -13,7 13.02% | -9,35 -8,60 -8.66% | -12,7 -11,0 -14.96% | -16,3 -17,6 7.33% | -13,3 |
|
EPS USD | Released Forecast Spread | -0,09 -0,06 -35.09% | -0,06 -0,07 13.23% | -0,05 -0,04 -15.29% | -0,06 -0,04 -34.78% | -0,07 -0,06 -21.38% | -0,05 |
| Announcement Date | 28/02/20 | 21/02/21 | 22/02/22 | 27/02/23 | 29/01/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2023 S1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,05 0,70 50.57% | 2,39 2,90 -17.69% | 3,92 2,90 35% | 5,03 6,25 -19.47% | 5,41 6,00 -9.81% | |
|
EBITDA Million USD | Released Forecast Spread | -6,53 -6,90 5.38% | -4,92 -3,50 -40.57% | -6,40 -4,10 -56.1% | |||
|
EBIT Million USD | Released Forecast Spread | -6,87 -7,30 5.85% | -5,32 -6,90 22.97% | -5,21 -4,90 -6.33% | -6,58 -4,90 -34.34% | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,70 -7,30 8.29% | -5,15 -4,10 -25.62% | -6,59 -4,90 -34.47% | |||
|
Net income Million USD | Released Forecast Spread | -6,70 -7,30 8.29% | -5,15 -4,10 -25.62% | -6,59 -4,90 -34.47% | -8,61 | ||
|
EPS USD | Released Forecast Spread | -0,04 | |||||
| Announcement Date | 25/08/20 | 21/02/21 | 29/08/21 | 22/02/22 | 24/08/22 | 30/08/23 |
More events
Past sector events for Next Science Limited
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NXS Stock
- Calendar Next Science Limited
